Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1970-8-7
|
| pubmed:language |
hrv
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:volume |
20
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
101-5
|
| pubmed:dateRevised |
2009-11-9
|
| pubmed:meshHeading |
pubmed-meshheading:4987221-Antitubercular Agents,
pubmed-meshheading:4987221-Catalase,
pubmed-meshheading:4987221-Drug Resistance, Microbial,
pubmed-meshheading:4987221-Humans,
pubmed-meshheading:4987221-Isoniazid,
pubmed-meshheading:4987221-Mycobacterium tuberculosis,
pubmed-meshheading:4987221-Peroxidases,
pubmed-meshheading:4987221-Tuberculosis, Pulmonary
|
| pubmed:articleTitle |
[Comparison of the clinical course of tuberculosis in patients infected with INH resitans catalase positive and catalase negative strains].
|
| pubmed:publicationType |
Journal Article
|